217 filings
8-K
MREO
Mereo Biopharma Group Plc
14 Jun 24
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
4:30pm
424B5
MREO
Mereo Biopharma Group Plc
14 Jun 24
Prospectus supplement for primary offering
4:15pm
8-K
MREO
Mereo Biopharma Group Plc
11 Jun 24
Regulation FD Disclosure
9:15pm
EFFECT
MREO
Mereo Biopharma Group Plc
28 May 24
Notice of effectiveness
12:15am
8-K
MREO
Mereo Biopharma Group Plc
23 May 24
Submission of Matters to a Vote of Security Holders
4:16pm
S-3
4vizv6
15 May 24
Shelf registration
4:49pm
10-Q
1gliy2ji63pj
15 May 24
Quarterly report
4:19pm
8-K
ddw u0y4o
15 May 24
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
ARS
j7mbh7kg zhndc
24 Apr 24
Annual report to shareholders
7:36am
DEF 14A
bxl hkssy4kvosvz4nc
24 Apr 24
Definitive proxy
7:30am
8-K
l57zk9j5 3wk0d2jvmds
15 Apr 24
Entry into a Material Definitive Agreement
7:30am
10-K
9qd2e83ao nyapyx
27 Mar 24
Annual report
5:20pm
8-K
vh6so6ziu8eds4c4
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
S-8
c9zeqlddtio gbhduo
23 Jan 24
Registration of securities for employees
4:16pm
8-K
svfpjlk0n
8 Jan 24
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
7:08am
8-A12B/A
bdjkd axjg6p
18 Dec 23
Registration of securities on exchange (amended)
4:16pm
6-K
d99nt6tr p1n2cna3x3
18 Dec 23
Current report (foreign)
4:10pm
6-K
gcpor
29 Nov 23
Current report (foreign)
4:15pm
6-K
44ytu2m74oxyg
16 Nov 23
Current report (foreign)
7:01am
6-K
wp0bkqgul8ydmh pn
23 Oct 23
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
4:08pm